Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: A phase 3, randomized clinical trial

Peter Vink, Josep Maria Ramon Torrell, Ana Sanchez Fructuoso, Sung Joo Kim, Sang Il Kim, Jeff Zaltzman, Fernanda Ortiz, Josep Maria Campistol Plana, Ana Maria Fernandez Rodriguez, Henar Rebollo Rodrigo, Magda Campins Marti, Rafael Perez, Francisco Manuel González Roncero, Deepali Kumar, Yang Jen Chiang, Karen Doucette, Lissa Pipeleers, Maria Luisa Agüera Morales, Maria Luisa Rodriguez-Ferrero, Antonio SecchiShelly A. McNeil, Laura Campora, Emmanuel Di Paolo, Mohamed El Idrissi, Marta López-Fauqued, Bruno Salaun, Thomas C. Heineman, Lidia Oostvogels

Research output: Contribution to journalArticlepeer-review

149 Citations (Scopus)
Original languageEnglish
Pages (from-to)181-190
Number of pages10
JournalClinical Infectious Diseases
Volume70
Issue number2
DOIs
Publication statusPublished - Jan 15 2020

ASJC Scopus Subject Areas

  • Microbiology (medical)
  • Infectious Diseases

Keywords

  • Herpes zoster vaccine
  • Immunogenicity
  • Immunosuppression
  • Renal transplant
  • Safety

Fingerprint

Dive into the research topics of 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in chronically immunosuppressed adults following renal transplant: A phase 3, randomized clinical trial'. Together they form a unique fingerprint.

Cite this